Cargando…
Association between hyperkalemia, RAASi non-adherence and outcomes in chronic kidney disease
BACKGROUND: Hyperkalemia is relatively frequent in CKD patients treated with renin-angiotensin-aldosterone-system inhibitors (RAASi). AIM: The aim of the present study was to estimate the increased risk of cardiovascular events and mortality due to sub-optimal adherence to RAASi in CKD patients with...
Autores principales: | Santoro, Antonio, Perrone, Valentina, Giacomini, Elisa, Sangiorgi, Diego, Alessandrini, Davide, Degli Esposti, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927011/ https://www.ncbi.nlm.nih.gov/pubmed/34115311 http://dx.doi.org/10.1007/s40620-021-01070-6 |
Ejemplares similares
-
Effects of hyperkalaemia and non‐adherence to renin–angiotensin–aldosterone system inhibitor therapy in patients with heart failure in Italy: a propensity‐matched study
por: Volterrani, Maurizio, et al.
Publicado: (2020) -
Management of RAASi-associated hyperkalemia in patients with cardiovascular disease
por: Silva-Cardoso, José, et al.
Publicado: (2021) -
Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia
por: Kanda, Eiichiro, et al.
Publicado: (2023) -
Evidence of Antibiotic Resistance from Population-Based Studies: A Narrative Review
por: Giacomini, Elisa, et al.
Publicado: (2021) -
Treatment Patterns and Pharmacoutilization in Patients Affected by Psoriasis: An Observational Study in an Italian Real-World Setting
por: Perrone, Valentina, et al.
Publicado: (2022)